Waaree Renewable Technologies Limited (WAAREERTL)
Press Release (Revised)
Press Release - Q2FY27
- Revenue 1,057.84 Cr +36.53% y-y; EBITDA 159.98 Cr +1.29% y-y; PAT 81.48 Cr -29.98% y-y
- H1 FY27 revenue 1,982.09 Cr +43.84% y-y; EBITDA 333.46 Cr +21.04% y-y; PAT 200.44 Cr -1.14% y-y
- Growth driven by steady project execution and expanded capabilities in renewable EPC and T&D
- Acquisition of APSPL strengthens T&D presence; pursuing Battery Energy Storage and Data Centre EPC
- Strong unexecuted order book of Rs. 5,500+ Cr and robust bidding pipeline
- Government policy support with Green Energy Corridor Phase-III and Surya Sarovar Yojana expanding clean energy opportunities
- Focus on operational efficiencies, business integration, and long-term value creation
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 WAAREERTL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add WAAREERTL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Waaree Renewable Technologies Limited
Important.
The summary above is generated automatically from Waaree Renewable Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.